Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Cell Reports. Medicine|December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART MoleculeAlexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Journal of the American Dental Association (1939)|May 2, 2013
An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: efficacy, tolerability and compliance with label dose administration directionsElliot V Hersh, Sebastian G Ciancio, Arthur S Kuperstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
ZW191, a FRα-targeted topoisomerase 1 inhibitor ADC with a differentiated antitumor efficacy and tolerability profileSamuel Lawn, Andrea Hernandez Rojas, Jodi Wong, et al.
Oncoimmunology|April 11, 2018
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasmsPaola Circosta, Angela Rita Elia, Indira Landra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2012
Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activityDeryk Loo, Ralph F Alderson, Francine Z Chen, et al.
Clinical Proteomics|August 18, 2015
Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumCharles E Birse, Robert J Lagier, William FitzHugh, et al.
Immunity|March 26, 2002
TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulatorThi Sau Migone, Jun Zhang, Xia Luo, et al.
Pageof 18